Clinical Trial Update: Liposomal Bupivacaine To Control Post-Operative Pain Following BMG [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating liposomal bupivacaine for post-operative pain control after buccal mucosa grafting (BMG) surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urethral Stricture

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Urology of Virginia | Conditions: Urethral Stricture | Phase 3 | Status: COMPLETED